Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.18 USD | +3.04% | +15.43% | -24.20% |
04-15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
03-25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Other languages